Purinergic P2Y Receptor Antagonists (definition)

encyclopedia of medical concepts

ψ ψ	Purinergic P2Y Receptor Antagonists

More information in Books or on

Definition: Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes.

Other names P2Y1 Purinoceptor Antagonists; ADP Receptor Blockers; ADP Receptor Antagonists; Receptor Blockers, ADP; Receptor Antagonists, ADP; Purinoceptor Antagonists, P2Y2; Purinoceptor Antagonists, P2Y12; Purinoceptor Antagonists, P2Y1; Purinoceptor Antagonists, P2Y; Blockers, ADP Receptor; Antagonists, P2Y2 Purinoceptor; Antagonists, P2Y12 Purinoceptor; Antagonists, P2Y1 Purinoceptor; Antagonists, P2Y Purinoceptor; Antagonists, ADP Receptor; Purinergic P2Y2 Receptor Antagonists; Purinergic P2Y12 Receptor Antagonists; Purinergic P2Y1 Receptor Antagonists; P2Y2 Purinoceptor Antagonists; P2Y12 Purinoceptor Antagonists

Substances having this pharmacologic action: Ticlopidine; N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate; cangrelor; prasugrel; Ticagrelor; clopidogrel

Substance	CAS Registry & name	Categories	Source	Drugs*
2-chloro-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate	0	Adenosine Diphosphate/*analogs & derivatives Purinergic P2Y Receptor Antagonists.	Br J Pharmacol 2002 Apr;135(8):2004-10

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link

Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor

We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy